Categories AlphaGraphs, Earnings, Retail
Chipotle Mexican Grill serves better-than-expected Q4 earnings
Chipotle Mexican Grill (CMG) Wednesday delivered fourth-quarter earnings of $1.72 per share, which came in well above analysts’ projection of $1.37 per share. Revenues gained 10.4% to $1.22 billion, surpassing the street consensus of $1.19 billion, driven by a 6.1% increase in comparable restaurant sales and new restaurant openings.
The increase in comp sales was primarily due to an increase in average check as well as a 2% increase in comparable restaurant transactions.
CMG stock popped over 7.5% during after-market trading on Wednesday.
In Q4, digital sales jumped 65.6%, accounting for about 13% of overall sales.
Brian Niccol, who became the chief of Chipotle after a successful stint as rival Yum Brands’ (YUM) Taco Bell, said, “For the full year, Chipotle’s average unit volumes exceeded $2 million with digital sales surpassing half a billion dollars. The growth acceleration this quarter gives us confidence that our strategy is working.”
For 2019, the Newport Beach, California-based restaurant chain expects comparable restaurant sales growth in the mid-single digit range.
The company also expects to open 140 to 155 new restaurants during this period. In the fourth quarter, Chipotle opened 40 new restaurants and closed or relocated 12.
Despite being marred by repeated food poisoning incidents, CMG stock had a great run in 2018. In the past 52 weeks, Chipotle has gained 78%, with the stock hitting a three-month-high last week. However, this is still a far cry from Chipotle’s 2015-high of $749.12.
LISTEN TO: CHIPOTLE MEXICAN GRILL Q4 2018 EARNINGS CONFERENCE CALL
The restaurant store chain has been rejigging its menu to include healthier options for diet-conscious customers. The company, which is often criticized for providing only high-calorie food items, hopes this kind of menu expansion would help bring in more customers, and in turn, improve the lackluster traffic numbers.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report
Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results
Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a